Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigulixostat in gout patients with hyperuricemia
NCT05586958Phase 3Completed
- Sponsor
- LG Chem
- Start
- Oct 2022
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of tigulixostat in gout, hyperuricemia, sponsored by LG Chem. Started Oct 2022; status: completed.
02
Drugs
tigulixostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on NCT05586958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05586958.